Sara Bonstein - Jan 4, 2024 Form 4 Insider Report for INSMED Inc (INSM)

Role
Chief Financial Officer
Signature
/s/ Sara Bonstein, by Michael A. Smith as Attorney in Fact
Stock symbol
INSM
Transactions as of
Jan 4, 2024
Transactions value $
$0
Form type
4
Date filed
1/5/2024, 05:27 PM
Previous filing
Dec 22, 2023
Next filing
Jan 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Award +12.9K +12.18% 119K Jan 4, 2024 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Award $0 +63.6K $0.00 63.6K Jan 4, 2024 Common Stock 63.6K $29.13 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.
F2 Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration.
F3 Includes 434 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
F4 Stock options granted under the Company's Amended and Restated 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.